Predicting Residual Cancer Burden In A Triple Negative Breast Cancer Cohort

Analysis and interpretation of stained histopathology sections is one of the main tools in cancer diagnosis and prognosis. In addition to the information which is typically extracted by trained pathologists, there is also information that is not yet exploited, simply because we do not yet understand the impact of all cellular and tissular features that could be predictive of outcome. In this paper, we address a question that can currently not be solved by pathologists: the prediction of treatment efficiency for Triple Negative Breast Cancer (TNBC) patients from biopsy data.

[1]  B. S. Manjunath,et al.  Use of imperfectly segmented nuclei in the classification of histopathology images of breast cancer , 2010, 2010 IEEE International Conference on Acoustics, Speech and Signal Processing.

[2]  Sanchit Gupta,et al.  Convolutional neural networks for prostate cancer recurrence prediction , 2017, Medical Imaging.

[3]  Zhipeng Jia,et al.  Large scale tissue histopathology image classification, segmentation, and visualization via deep convolutional activation features , 2017, BMC Bioinformatics.

[4]  K. Hirakawa,et al.  Prediction of survival after neoadjuvant chemotherapy for breast cancer by evaluation of tumor-infiltrating lymphocytes and residual cancer burden , 2017, BMC Cancer.

[5]  Jian Sun,et al.  Deep Residual Learning for Image Recognition , 2015, 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR).

[6]  Zhuowen Tu,et al.  Context-Constrained Multiple Instance Learning for Histopathology Image Segmentation , 2012, MICCAI.

[7]  Matthieu Cord,et al.  WELDON: Weakly Supervised Learning of Deep Convolutional Neural Networks , 2016, 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR).

[8]  Catarina Eloy,et al.  BACH: Grand Challenge on Breast Cancer Histology Images , 2018, Medical Image Anal..

[9]  Meyke Hermsen,et al.  1399 H&E-stained sentinel lymph node sections of breast cancer patients: the CAMELYON dataset , 2018, GigaScience.

[10]  Geoffrey E. Hinton,et al.  ImageNet classification with deep convolutional neural networks , 2012, Commun. ACM.

[11]  Thomas Walter,et al.  Segmentation of Nuclei in Histopathology Images by Deep Regression of the Distance Map , 2019, IEEE Transactions on Medical Imaging.

[12]  Jimmy Ba,et al.  Adam: A Method for Stochastic Optimization , 2014, ICLR.

[13]  Leo Breiman,et al.  Random Forests , 2001, Machine Learning.

[14]  Eric W. Tramel,et al.  Classification and Disease Localization in Histopathology Using Only Global Labels: A Weakly-Supervised Approach , 2018, ArXiv.

[15]  Junzhou Huang,et al.  WSISA: Making Survival Prediction from Whole Slide Histopathological Images , 2017, 2017 IEEE Conference on Computer Vision and Pattern Recognition (CVPR).

[16]  Christos Hatzis,et al.  Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  Karl Rohr,et al.  Predicting breast tumor proliferation from whole‐slide images: The TUPAC16 challenge , 2018, Medical Image Anal..